spiraprilat has been researched along with Blood Pressure, High in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haufe, CC; Jansa, U; Sierakowski, B; Stein, G | 1 |
Elliott, HL; Grass, P; Guitard, C; Meredith, PA | 1 |
Duchiez, J; Guitard, C; Safar, ME; Sassano, P; Tzincoca, C | 1 |
Hayduk, K; Kraul, H | 1 |
1 review(s) available for spiraprilat and Blood Pressure, High
Article | Year |
---|---|
Efficacy and safety of spirapril in mild-to-moderate hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Interactions; Enalapril; Humans; Hypertension; Prodrugs | 1999 |
3 trial(s) available for spiraprilat and Blood Pressure, High
Article | Year |
---|---|
[Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Enalapril; Female; Humans; Hypertension; Kidney Failure, Chronic; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged | 1994 |
Pharmacokinetics of spirapril in renal impairment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Creatinine; Enalapril; Humans; Hypertension; Kidney Diseases; Single-Blind Method | 1994 |
Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Renin-Angiotensin System | 1994 |